New York · 2025-2026 session
Status: In committee
Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.
REFERRED TO HIGHER EDUCATION (2026-01-07)